Immune reconstitution in HIV-1-infected children on antiretroviral therapy: Role of thymic output and viral fitness

AIDS

Volumn 16, Issue 6, 2002, Pages 839-849

  Ometto, Lucia ^a   De Forni, Davide ^a   Patiri, Fiorulla ^a   Trouplin, Virginie ^a   Mammano, Fabrizio ^a   Giacomet, Vania ^a   Giaquinto, Carlo ^a   Douek, Daniel ^a   Koup, Richard ^a   De Rossi, Anita ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiretroviral therapy; Children; HIV 1; Thymus; Viral replication

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; T LYMPHOCYTE RECEPTOR; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CELL COUNT; CELL LOSS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS; TREATMENT OUTCOME; TREATMENT PLANNING; VIREMIA; VIRUS REPLICATION;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; THYMUS GLAND; VIRAL LOAD; VIRULENCE;

EID: 0037066355     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200204120-00003     Document Type: Article

References (49)

1. Dynamics of HIV-1 and CD4+ lymphocytes in vivo
2. Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy
3. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
4. The CD4+ T cell response to HIV-1
5. Immune restoration with antiretroviral therapies
6. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
7. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
8. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
9. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
10. Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues
11. Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling
12. Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy
13. Immune reconstitution in HAART-treated children with AIDS
14. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children
15. Immune repopulation after HAART in previously untreated HIV-1-infected children
16. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy
17. Thymic involution with ageing: Obsolescence or good housekeeping?
18. HIV-1 and the thymus
19. Changes in thymic function with age and during the treatment of HIV infection
20. T cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells
21. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy
22. Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus
23. Effect of HIV on thymic function before and after antiretroviral therapy in children
24. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort study
25. Improvement in CD4+ T cell counts despite persistently detectable HIV load
26. Immune reconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages
27. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage of HIV-1 disease
28. Dissociation of immunologic and virologic responses to highly active antiretroviral therapy
29. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: Role of changes in thymic output and T cell death
30. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus
31. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission
32. Coreceptor usage of primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission
33. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection
34. Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies
35. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients
36. Loss of viral fitness associated with multiple gag and gag-pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors
37. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo
38. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
39. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals
40. Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: Virus fitness in the absence and in the presence of drug
41. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
42. International perspectives on antiretroviral resistance. Resistance to prothease inhibitors
43. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
44. Distribution of human immunodeficiency virus coreceptors CXCR4 and CCR5 in fetal lymphoid organs: Implications for pathogenesis in utero
45. High viral burden and rapid CD4+cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo
46. Differential tropism and replication kinetics of human immunodeficiency type 1 isolates in thymocytes: Coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level
47. Recovery of replication-competent from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy
48. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naïve T cell population in HIV-1 infection
49. HIV-1 infection of the thymus: Evidence for a cytopathic and thymotropic viral variants in vivo